# US 2025/0367114 A1 · Inhalable composition for enhancing alertness and vitality and device for supplying the inhalable composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367114 A1
- Document ID: US20250367114A1
- Status: Published application
- Kind: A1
- Application number: 19/193,021
- Filed: 2025-04-29
- Published: 2025-12-04
- Earliest claimed: 2024-05-31
- Assignees: Kt&G Corporation
- Applicants: Kt&G Corporation
- Inventors: Young Chul LEE; So Eun KIM; Sung Ok MOON; Bo Young LEE; Hwa Chul JUNG; Han Jae SHIN
- Web page: https://patentgrep.com/patent/US20250367114A1

## CPC

- A61K 9/0075: {for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles}
- A61K 9/0073: {Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; (nasal sprays A61K9/0043; inhalation of vapours of volatile or heated drugs, e.g. essential oils or nicotine, A61K9/007; devices A61M)}
- A61K 9/0078: {for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions}
- A61K 9/008: {comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]}
- A61K 31/455: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A61K 31/52: Purines, e.g. adenine
- A61K 31/7004: Monosaccharides having only carbon, hydrogen and oxygen atoms
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61P 25/26: Psychostimulants, e.g. nicotine, cocaine
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

In an inhalable composition for enhancing alertness and vitality according to an embodiment, the composition includes caffeine and an enhancing agent including one or more selected from glucose and magnesium.

## Claims

### Claim 1

An inhalable composition for enhancing alertness and vitality, comprising:
caffeine; and
an enhancing agent comprising one or more selected from glucose and magnesium.

### Claim 2 (depends on 1)

The inhalable composition of claim 1, wherein, based on a total weight of the inhalable composition, a content of caffeine is 15 wt % or less.

### Claim 3 (depends on 1)

The inhalable composition of claim 1, wherein, based on a total weight of the inhalable composition, a content of caffeine is 8 wt % or less.

### Claim 4 (depends on 1)

The inhalable composition of claim 1, further comprising:
vitamin B3; and
at least one solvent selected from a group comprising water, alcohol, propylene glycol, and vegetable glycerin.

### Claim 5 (depends on 4)

The inhalable composition of claim 4, wherein a weight ratio of the caffeine to the vitamin B3 is 2:1 to 2:3.

### Claim 6 (depends on 4)

The inhalable composition of claim 4, wherein, based on a total weight of the inhalable composition,
a content of caffeine is 2 wt % to 15 wt %,
a content of vitamin B3 is 1 wt % to 15 wt %,
a content of enhancing agent is 1 wt % to 20 wt %, and
a content of solvent is 45 wt % to 96 wt %.

### Claim 7 (depends on 4)

The inhalable composition of claim 4, wherein the solvent comprises 98.5 wt % to 99.5 wt % water and 0.5 wt % and 1.5 wt % sodium chloride, based on a total weight of the solvent.

### Claim 8 (depends on 6)

The inhalable composition of claim 6, wherein, based on a total weight of the inhalable composition, the enhancing agent comprises 1 wt % to 10 wt % glucose and 1 wt % to 10 wt % magnesium.

### Claim 9

A device for supplying an inhalable composition, the device comprising:
a storage container storing an inhalable composition comprising caffeine and an enhancing agent comprising one or more selected from glucose and magnesium; and
an inhaler coupled to the storage container.

### Claim 10 (depends on 9)

The device of claim 9, wherein the inhaler is a metered-dose inhaler, a dry powder inhaler, or a nebulizer.

### Claim 11 (depends on 9)

The device of claim 9, wherein the inhalable composition further comprises vitamin B3 and at least one solvent selected from a group comprising water, alcohol, propylene glycol, and vegetable glycerin, and
the inhaler comprises an atomizer configured to atomize the inhalable composition.

### Claim 12 (depends on 11)

The device of claim 11, wherein the atomizer is configured to atomize the inhalable composition using a jet method, an ultrasonic method, a vibration method, or a heating method.
